17
Jun
2026
17
Jun
2026
Leading aesthetics company DermaFocus has hosted a series of regional launch events across the UK to introduce aesthetic practitioners to Celora™ Vita, a new injectable designed to support TRUE BIORESTORATION®.
The events were attended by healthcare professionals from across the UK and focused on information about the product, including its science, clinical applications, and treatment protocols.
The sessions included presentations from DermaFocus Faculty Members, including Dr Racquel Amado and Dr Jordan Faulkener, as well as practitioners who have begun incorporating Celora™ Vita into patient treatment plans.
Attendees were able to hear about early clinical experience with the product and discuss its use in practice.
Celora™ Vita was launched at this year’s Aesthetic Conference & Exhibition (ACE). It is the first proprietary product in DermaFocus’ portfolio of regenerative aesthetics solutions.
DermaFocus said the regional events form part of its ongoing focus on practitioner education and providing access to developments in aesthetic medicine.
Co-Founder and Executive Director of DermaFocus, Milad Bemana, comments:
“DermaFocus is committed to innovation and excellence in regenerative aesthetics, and the launch of Celora™ Vita marked a significant new chapter in our company’s history as we evolved to becoming a brand owner and category leader.
Our Celora™ Vita regional launch events gave us a valuable opportunity to engage with our community at a regional level, and allowed practitioners to engage with industry friends, deepen their understanding of the product, and explore how this innovative biorestorative treatment can support patient outcomes.
We were delighted with the feedback from practitioners at each event, who are excited to introduce Celora™ Vita and the category of TRUE BIORESTORATION® to their patients and treatment menus.”
Read it? Loved it? Want to share it?
